Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation

David Fgj Wolthuis, Miriam C. Janssen, David Cassiman, Dirk J. Lefeber, Eva Morava-Kozicz

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Congenital disorders of N-glycosylation (CDG) form a rapidly growing group of more than 20 inborn errors of metabolism. Most patients are identified at the pediatric age with multisystem disease. There is no systematic review on the long-term outcome and clinical presentation in adult patients. Here, we review the adult phenotype in 78 CDG patients diagnosed with 18 different forms of N-glycosylation defects. Characteristics include intellectual disability, speech disorder and abnormal gait. After puberty, symptoms might remain non-progressive and patients may lead a socially functional life. Thrombosis and progressive symptoms, such as peripheral neuropathy, scoliosis and visual demise are specifically common in PMM2-CDG. Especially in adult patients, diagnostic glycosylation screening can be mildly abnormal or near-normal, hampering diagnosis. Features of adult CDG patients significantly differ from the pediatric phenotype. Non-syndromal intellectual disability, or congenital malformations in different types of CDG and decreasing sensitivity of screening might be responsible for the CDG cases remaining undiagnosed until adulthood.

Original languageEnglish (US)
Pages (from-to)217-224
Number of pages8
JournalExpert Review of Molecular Diagnostics
Volume14
Issue number2
DOIs
StatePublished - Mar 1 2014
Externally publishedYes

Fingerprint

Congenital Disorders of Glycosylation
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Glycosylation
Phenotype
Intellectual Disability
Pediatrics
Speech Disorders
Inborn Errors Metabolism
Scoliosis
Peripheral Nervous System Diseases
Puberty
Gait
Thrombosis

Keywords

  • adult metabolic disease
  • ataxia
  • cataract
  • CDG
  • N-linked glycosylation
  • scoliosis
  • thrombosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation. / Wolthuis, David Fgj; Janssen, Miriam C.; Cassiman, David; Lefeber, Dirk J.; Morava-Kozicz, Eva.

In: Expert Review of Molecular Diagnostics, Vol. 14, No. 2, 01.03.2014, p. 217-224.

Research output: Contribution to journalReview article

Wolthuis, David Fgj ; Janssen, Miriam C. ; Cassiman, David ; Lefeber, Dirk J. ; Morava-Kozicz, Eva. / Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation. In: Expert Review of Molecular Diagnostics. 2014 ; Vol. 14, No. 2. pp. 217-224.
@article{28d8e3f5197641e184093da3387fa57c,
title = "Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation",
abstract = "Congenital disorders of N-glycosylation (CDG) form a rapidly growing group of more than 20 inborn errors of metabolism. Most patients are identified at the pediatric age with multisystem disease. There is no systematic review on the long-term outcome and clinical presentation in adult patients. Here, we review the adult phenotype in 78 CDG patients diagnosed with 18 different forms of N-glycosylation defects. Characteristics include intellectual disability, speech disorder and abnormal gait. After puberty, symptoms might remain non-progressive and patients may lead a socially functional life. Thrombosis and progressive symptoms, such as peripheral neuropathy, scoliosis and visual demise are specifically common in PMM2-CDG. Especially in adult patients, diagnostic glycosylation screening can be mildly abnormal or near-normal, hampering diagnosis. Features of adult CDG patients significantly differ from the pediatric phenotype. Non-syndromal intellectual disability, or congenital malformations in different types of CDG and decreasing sensitivity of screening might be responsible for the CDG cases remaining undiagnosed until adulthood.",
keywords = "adult metabolic disease, ataxia, cataract, CDG, N-linked glycosylation, scoliosis, thrombosis",
author = "Wolthuis, {David Fgj} and Janssen, {Miriam C.} and David Cassiman and Lefeber, {Dirk J.} and Eva Morava-Kozicz",
year = "2014",
month = "3",
day = "1",
doi = "10.1586/14737159.2014.890052",
language = "English (US)",
volume = "14",
pages = "217--224",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation

AU - Wolthuis, David Fgj

AU - Janssen, Miriam C.

AU - Cassiman, David

AU - Lefeber, Dirk J.

AU - Morava-Kozicz, Eva

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Congenital disorders of N-glycosylation (CDG) form a rapidly growing group of more than 20 inborn errors of metabolism. Most patients are identified at the pediatric age with multisystem disease. There is no systematic review on the long-term outcome and clinical presentation in adult patients. Here, we review the adult phenotype in 78 CDG patients diagnosed with 18 different forms of N-glycosylation defects. Characteristics include intellectual disability, speech disorder and abnormal gait. After puberty, symptoms might remain non-progressive and patients may lead a socially functional life. Thrombosis and progressive symptoms, such as peripheral neuropathy, scoliosis and visual demise are specifically common in PMM2-CDG. Especially in adult patients, diagnostic glycosylation screening can be mildly abnormal or near-normal, hampering diagnosis. Features of adult CDG patients significantly differ from the pediatric phenotype. Non-syndromal intellectual disability, or congenital malformations in different types of CDG and decreasing sensitivity of screening might be responsible for the CDG cases remaining undiagnosed until adulthood.

AB - Congenital disorders of N-glycosylation (CDG) form a rapidly growing group of more than 20 inborn errors of metabolism. Most patients are identified at the pediatric age with multisystem disease. There is no systematic review on the long-term outcome and clinical presentation in adult patients. Here, we review the adult phenotype in 78 CDG patients diagnosed with 18 different forms of N-glycosylation defects. Characteristics include intellectual disability, speech disorder and abnormal gait. After puberty, symptoms might remain non-progressive and patients may lead a socially functional life. Thrombosis and progressive symptoms, such as peripheral neuropathy, scoliosis and visual demise are specifically common in PMM2-CDG. Especially in adult patients, diagnostic glycosylation screening can be mildly abnormal or near-normal, hampering diagnosis. Features of adult CDG patients significantly differ from the pediatric phenotype. Non-syndromal intellectual disability, or congenital malformations in different types of CDG and decreasing sensitivity of screening might be responsible for the CDG cases remaining undiagnosed until adulthood.

KW - adult metabolic disease

KW - ataxia

KW - cataract

KW - CDG

KW - N-linked glycosylation

KW - scoliosis

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84894528563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894528563&partnerID=8YFLogxK

U2 - 10.1586/14737159.2014.890052

DO - 10.1586/14737159.2014.890052

M3 - Review article

C2 - 24524732

AN - SCOPUS:84894528563

VL - 14

SP - 217

EP - 224

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 2

ER -